The market expects Amedisys (AMED) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...

Amedisys’ AMED growth in the third quarter ... to acquire all of the outstanding shares of Amedisys’ common stock in an all-cash transaction for $101 per share. Combining Optum's extensive ...

with Amedisys surviving the Merger as a wholly owned subsidiary of Unite Amedisys stock climbed Friday after the provider of home health care agreed to waive its right to terminate a merger ...

Stock analysts at Leerink Partnrs raised their FY2026 earnings per share estimates for shares of Amedisys in a research ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

In a report released on January 29, Whit Mayo from Leerink Partners reiterated a Hold rating on Amedisys (AMED – Research Report), with a price ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.